ATXI
Avenue Therapeutics, Inc. Common Stock
ATXI
ATXI
Delisted
ATXI was delisted on the 18th of March, 2025.
7 hedge funds and large institutions have $385K invested in Avenue Therapeutics, Inc. Common Stock in 2024 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 3 increasing their positions, 1 reducing their positions, and 4 closing their positions.
Holders
7
Holders Change
-1
Holders Change %
-12.5%
% of All Funds
0.09%
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
3
Increased
3
Reduced
1
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
1 |
IC
1
Ikarian Capital
Dallas,
Texas
|
$280K |
2 |
BFM
2
Boothbay Fund Management
New York
|
$82.2K |
3 |
3
UBS Group
Zurich,
Switzerland
|
$15.8K |
4 |
TRCT
4
Tower Research Capital (TRC)
New York
|
$6.19K |
5 |
SS
5
SBI Securities
Tokyo,
Japan
|
$18 |